Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rudoltz

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|June 29, 1995
Staging of head and neck cancerG D Kao, M Rudoltz
Biomaterials|September 1, 1986
Crosslinked polyether/polysiloxane networks for blood-interfacing applicationsR W Pekala, M Rudoltz, E R Lang, et al.
Leukemia|March 14, 2009
Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemiaA Hochhaus, S G O'Brien, F Guilhot, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|June 29, 1995
Staging of head and neck cancerG D Kao, M Rudoltz
Biomaterials|September 1, 1986
Crosslinked polyether/polysiloxane networks for blood-interfacing applicationsR W Pekala, M Rudoltz, E R Lang, et al.
Leukemia|March 14, 2009
Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemiaA Hochhaus, S G O'Brien, F Guilhot, et al.
Pageof 1